Table 1.

Baseline demographic data by treatment group for 208 randomized subjects

Demographic measuresPlacebo, n = 50150 mg bid, n = 51300 mg bid, n = 53600 mg bid, n = 54
* p = 0.038 vs placebo, uncorrected for number of comparisons.
Age, y, mean ± SD52.0 ± 1.753.4 ± 1.450.0 ± 1.752.8 ± 1.8
Sex, M/F30/2034/1731/2232/22
Diabetes, y, mean ± SD10.5 ± 1.211.3 ± 1.413.7 ± 1.310.0 ± 1.1
Type 1 diabetes, %20.021.634.022.2
Diabetic polyneuropathy duration, y, mean ± SD3.1 ± 0.52.7 ± 0.43.5 ± 0.73.1 ± 0.4
Glycosylated hemoglobin, %, mean ± SD10.3 ± 0.310.0 ± 0.311.2 ± 0.2*10.4 ± 0.3